Genus PLC saw its shares drop 8.2% on Monday after reporting adjusted full-year revenue below analyst expectations. For the fiscal year, the British animal genetics company recorded adjusted revenue of
The company reported adjusted revenue of
Genus said the fall in adjusted revenue - a 2% decline to ) from was primarily driven by the deconsolidation of PIC China, the company's Chinese porcine genetics operation, after that business was moved into a new joint venture with Beijing Capital Agribusiness.
Despite the revenue shortfall, Genus reported stronger profit metrics. Adjusted operating profit - when including joint ventures - grew by 25%. The company attributed that uplift to robust performance from PIC, a )
Key contributors to operating profit growth included a
Adjusted profit before tax increased 35% for the year. Excluding milestone payments that were received in both fiscal 2026 and fiscal 2025, adjusted profit before tax rose by 34%.
Looking ahead to fiscal 2027, Genus said its outlook is consistent with market expectations. The company expects to achieve resilient underlying profit growth despite cyclical weakness in some agricultural markets. Management guided that group adjusted profit before tax in constant currency should align with consensus estimates and be moderately above a normalized fiscal 2026 adjusted profit before tax of
Genus also expects moderate adjusted operating profit growth in both its Genus PIC and Genus ABS units for fiscal 2027. However, the company cautioned that adjusted profit before tax for the year is likely to be weighted toward the second half. The second-half bias reflects anticipated first-half challenges including disease-related issues affecting North American pork production, low pork prices in Brazil, and weak global dairy prices.